Table 4.
3 year Death/Transplant (27 events) |
||
---|---|---|
Variable | HR (95% CI) | p-value |
Univariable Model | ||
NGAL (ng/mL)* | 1.76 (1.19 – 2.58) | 0.004 |
| ||
Multivariable Model 1 | ||
NGAL (ng/mL)* | 1.68 (1.08 – 2.57) | 0.022 |
LVEF (%)* | 1.15 (0.71 – 1.88) | 0.578 |
Mitral E/Ea* | 1.21 (0.82 – 1.64) | 0.309 |
| ||
Multivariable Model 2 | ||
NGAL (ng/mL)* | 1.06 (0.66 – 1.84) | 0.831 |
Cystatin C (ng/mL)* | 1.69 (1.06 – 2.59) | 0.027 |
| ||
Multivariable Model 3 | ||
NGAL (ng/mL)* | 1.40 (0.92 – 2.21) | 0.117 |
NT-proBNP (pg/mL)* | 1.59 (1.03 – 2.48) | 0.038 |
Abbreviations: NGAL, neutrophil gelatinase-associated lipocalin; LVEF, left ventricular ejection fraction; NT-proBNP, amino-terminal pro-B-type natriuretic peptide.
All multivariable models adjusted for age and gender. Abbreviations: NGAL, cystatin C and NT-proBNP are natural logarithmic transformed. Hazard ratios per 1 SD increment (1 SD Ln NGAL = 0.58 ng/mL, 1 SD Age = 13.4 years; 1 SD LVEF = 5.9%; 1 SD E/septal Ea = 12.0; 1 SD Ln Cystatin C = 0.34 ng/mL; 1 SD Ln NT-proBNP = 1.27 pg/mL).